Information Journal Paper
APA:
Copy. (2018). Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted pegylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. NANOMEDICINE, 13(1), 3853-3866. SID. https://sid.ir/paper/786113/en
Vancouver:
Copy. Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted pegylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. NANOMEDICINE[Internet]. 2018;13(1):3853-3866. Available from: https://sid.ir/paper/786113/en
IEEE:
Copy, “Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted pegylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance,” NANOMEDICINE, vol. 13, no. 1, pp. 3853–3866, 2018, [Online]. Available: https://sid.ir/paper/786113/en